An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines (Q39825225)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 July 2009

edit

Language	Label	Description	Also known as
English	An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines	scientific article published on 15 July 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

title

An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

author

Efstathia Giannopoulou

object named as

Efstathia Giannopoulou

series ordinal

1

0 references

author name string

Konstantinos Dimitropoulos

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

Andreas A Argyriou

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

Angelos K Koutras

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

Fotinos Dimitrakopoulos

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

Haralabos P Kalofonos

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

publication date

15 July 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

published in

Investigational New Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

volume

28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

page(s)

554-560

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

cites work

SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10637-009-9290-0

retrieved

21 January 2018

The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of SHIP-1 on MMP2 secretion and invasion of SR3Y1 cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib in patients with metastatic renal cell carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amifostine has antiangiogenic properties in vitro by changing the redox status of human endothelial cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted molecular therapy of GBM.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lessons learned in the development of targeted therapy for malignant gliomas.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual targeting of EGFR and HER-2 in colon cancer cell lines.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecularly targeted therapy for malignant glioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet-derived growth factor in human glioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of trastuzumab on epidermal growth factor receptor-dependent and -independent human colon cancer cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma and various other solid tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparanase affects adhesive and tumorigenic potential of human glioma cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain metastasis in renal cell cancer responding to sunitinib.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19603143

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10637-009-9290-0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

PubMed publication ID

19603143

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19603143

retrieved

15 September 2017

ResearchGate publication ID

26671711

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39825225&oldid=2203199556"